In vitro synergy of eugenol and methyleugenol with fluconazole against clinical Candida isolates

Journal of Medical Microbiology

Volumn 59, Issue 10, 2010, Pages 1178-1184

  Ahmad, Aijaz ^a   Khan, Amber ^a   Khan, Luqman Ahmad ^a   Manzoor, Nikhat ^a  

^a JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EUGENOL; FLUCONAZOLE; METHYLEUGENOL; ANTIFUNGAL AGENT;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA; CANDIDIASIS; CONTROLLED STUDY; DRUG POTENTIATION; DRUG STRUCTURE; FUNGUS ISOLATION; IMMUNOCOMPROMISED PATIENT; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; ANALOGS AND DERIVATIVES; CHEMICAL STRUCTURE; DRUG EFFECTS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; DRUG SYNERGISM; EUGENOL; FLUCONAZOLE; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE;

EID: 77957301217     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.020693-0     Document Type: Article

References (28)

1. Ahmad, A., Khan, A., Manzoor, N. & Khan, L. A. (2010). Evolution of ergosterol biosynthesis inhibitors as fungicidal against Candida. Microb Pathog 48, 35-41.
2. Arif, T., Bhosale, J. D., Kumar, N., Mandal, T. K., Bendre, R. S., Lavekar, G. S. & Dabur, R. J. (2009). Natural products - antifungal agents derived from plants. J Asian Nat Prod Res 11, 621-638.
3. Berenbaum, M. C. (1989). What is synergy? Pharmacol Rev 41, 93-141.
4. Braga, P. C., Sasso, M. D., Culici, M. & Alfieri, M. (2007). Eugenol and thymol, alone or in combination, induce morphological alterations in the envelope of Candida albicans. Fitoterapia 78, 396-400.
5. Brammer, K. W., Farrow, P. R. & Faulkner, J. K. (1990). Pharmacokinetics and tissue penetration of fluconazole in humans. Rev Infect Dis 12, S318-S326.
6. Cantón, E., Pemán, J., Gobernado, M., Viudes, A. & Espinel, I. A. (2005). Synergistic activities of fluconazole and voriconazole with terbinafine against four Candida species determined by checkerboard, time-kill, and Etest methods. Antimicrob Agents Chemother 49, 1593-1596.
7. Chakrabarti, A., Chatterjee, S. S., Rao, K. L., Zameer, M. M., Shivaprakash, M. R., Singhi, S., Singh, R. & Varma, S. C. (2009). Recent experience with fungaemia: change in species distribution and azole resistance. Scand J Infect Dis 41, 275-284.
8. CLSI (2002). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts, approved standard M27-A2. Wayne, PA: Clinical and Laboratory Standards Institute.
9. Cowan, M. M. (1999). Plant products as antimicrobial agents. Clin Microbiol Rev 12, 564-582.
10. Eggimann, P., Garbino, J. & Pitte, D. (2003). Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 3, 685-702.
11. Filler, S. G. & Sheppard, D. C. (2006). Fungal invasion of normally non-phagocytic host cells. PLoS Pathog 2, e129.
12. Ghannoum, M. A., Fu, Y., Ibrahim, A. S., Mortara, L. A., Shafiq, M. C., Edwards, J. E., Jr & Criddle, R. S. (1995). In vitro determination of optimal antifungal combinations against Cryptococcus neoformans and Candida albicans. Antimicrob Agents Chemother 39, 2459-2465.
13. Guo, N., Liu, J., Wu, X., Bi, X., Meng, R., Wang, X., Xiang, H., Deng, X. & Yu, L. (2009). Antifungal activity of thymol against clinical isolates of fluconazole-sensitive and resistant Candida albicans. J Med Microbiol 58, 1074-1079.
14. Hadizadeh, I., Peivastegan, B. & Hamzehzarghani, H. (2009). Antifungal activity of essential oils from some medicinal plants of Iran against Alternaria alternate. Am J Appl Sci 6, 857-861.
15. Khan, A., Ahmad, A., Manzoor, N. & Khan, L. A. (2010). Antifungal activities of Ocimum sanctum essential oil and its lead molecules. Nat Prod Commun 5, 345-349.
16. Koehler, A. P., Chu, K. C., Houang, E. T. & Cheng, A. F. (1999). Simple, reliable and cost effective yeast identification scheme for the clinical laboratory. J Clin Microbiol 37, 422-426.
17. Mukherjee, P. K., Sheehan, D. J., Hitchcock, C. A. & Ghannoum, M. A. (2005). Combination treatment of invasive fungal infections. Clin Microbiol Rev 18, 163-194.
18. Onyewu, C., Blankenship, J. R., Del Poeta, M. & Heitman, J. (2003). Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei. Antimicrob Agents Chemother 47, 956-964.
19. Pina-Vaz, C., Gonçalves Rodrigues, A., Pinto, E., Costa-de-Oliveira, S., Tavares, C., Salgueiro, L., Cavaleiro, C., Gonçalves, M. J. & Martinez-de-Oliveira, J. (2004). Antifungal activity of Thymus oils and their major compounds. J Eur Acad Dermatol Venerol 18, 73-78.
20. Pinto, E., Pina-Vaz, C., Salgueiro, L., Goncalves, M. J., Costa-de- Oliveira, S., Cavaleiro, C., Palmeira, A., Rodrigues, A. & Martinez-de- Oliveira, J. (2006). Antifungal activity of the essential oil of Thymus pulegioides on Candida, Aspergillus and dermatophyte species. J Med Microbiol 55, 1367-1373. (Pubitemid 44651663)
21. Pinto, E., Vale-Silva, L., Cavaleiro, C. & Salgueiro, L. (2009). Antifungal activity of clove essential oil from Syzygium aromaticum on Candida, Aspergillus and dermatophyte species. J Med Microbiol 58, 1454-1462.
22. Rosato, A., Viali, C., Gallo, D., Millillo, M. A. & Mallamaci, R. (2008). The inhibition of Candida species by selected oils and their synergism with amphotericin B. Phytomedicine 15, 635-638.
23. Rosato, A., Vitali, C., Piarulli, M., Mazzotta, M., Argentieri, M. P. & Mallamaci, R. (2009). In vitro synergic efficacy of the combination of Nystatin with the essential oils of Origanum vulgare and Pelargonium graveolens against some Candida species. Phytomedicine 16, 972-975.
24. Sanglard, D., Ischer, F., Parkinson, T., Falconer, D. & Bille, J. (2003). Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents. Antimicrob Agents Chemother 47, 2404-2412.
25. Shin, S. & Pyun, M. S. (2004). Anti-Candida effects of estragole in combination with ketoconazole or amphotericin B. Phytother Res 18, 827-830.
26. Tariq, V. N., Scott, E. M. & McCain, N. E. (1995). Use of decimal assay for additivity to demonstrate synergy in pair combinations of econazole, nikkomycin Z, and ibuprofen against C. albicans in vitro. Antimicrob Agents Chemother 39, 2615-2619.
27. Uppuluri, P., Nett, J., Heitman, J. & Andes, D. (2008). Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms. Antimicrob Agents Chemother 52, 1127-1132.
28. Vanden Bossche, H., Willemsens, G. & Marichal, P. (1987). Anti- Candida drugs - the biochemical basis for their activity. Crit Rev Microbiol 15, 57-72.